ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 97 filers reported holding ALBIREO PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $960,694 | +98.5% | 44,303 | +77.5% | 0.00% | 0.0% |
| Q3 2022 | $484,000 | +14.2% | 24,962 | +17.0% | 0.00% | 0.0% |
| Q2 2022 | $424,000 | -30.0% | 21,330 | +5.1% | 0.00% | -33.3% |
| Q1 2022 | $606,000 | +156.8% | 20,300 | +100.0% | 0.00% | +200.0% |
| Q4 2021 | $236,000 | -21.1% | 10,150 | +5.8% | 0.00% | 0.0% |
| Q3 2021 | $299,000 | -11.5% | 9,596 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $338,000 | 0.0% | 9,596 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $338,000 | -8.6% | 9,596 | -2.8% | 0.00% | -50.0% |
| Q4 2020 | $370,000 | +12.5% | 9,869 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $329,000 | +26.1% | 9,869 | 0.0% | 0.00% | +100.0% |
| Q2 2020 | $261,000 | +29.2% | 9,869 | +24.1% | 0.00% | 0.0% |
| Q4 2019 | $202,000 | +0.5% | 7,951 | +27.7% | 0.00% | 0.0% |
| Q1 2019 | $201,000 | – | 6,225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 270,146 | $6,627,000 | 3.42% |
| Perceptive Advisors | 1,704,330 | $39,506,000 | 1.50% |
| Birchview Capital, LP | 38,000 | $932,000 | 0.88% |
| SECTORAL ASSET MANAGEMENT INC | 229,978 | $5,641,000 | 0.77% |
| BVF INC/IL | 200,500 | $4,918,000 | 0.64% |
| Artal Group S.A. | 500,000 | $12,265,000 | 0.45% |
| PA Capital LLC | 14,692 | $360,000 | 0.38% |
| Chicago Capital, LLC | 180,911 | $4,438,000 | 0.36% |
| TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $17,573,000 | 0.28% |
| Fosun International Ltd | 197,005 | $4,492,000 | 0.27% |